Free Trial

Summit Therapeutics (SMMT) Insider Trading & Ownership

Summit Therapeutics logo
$18.48 -0.14 (-0.75%)
(As of 10:31 AM ET)

Summit Therapeutics (NASDAQ:SMMT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
88.30%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$542,118.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get SMMT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Summit Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMMT Insider Buying and Selling by Quarter

Summit Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/26/2024Ankur DhingraCFOBuy100,000$3.75$375,000.00  
3/26/2024Mahkam ZanganehCEOBuy30,000$3.75$112,500.00  
12/13/2023Ankur DhingraCFOBuy20,400$2.17$44,268.00  
12/12/2023Mahkam ZanganehCEOBuy5,000$2.07$10,350.00  
(Data available from 1/1/2013 forward)

SMMT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Summit Therapeutics includes Ankur Dhingra, Mahkam Zanganeh, Manmeet Singh Soni, and Robert W Duggan. Learn more on insiders at SMMT.

88.30% of Summit Therapeutics stock is owned by insiders. Learn more on SMMT's insider holdings.

The following insiders have purchased SMMT shares in the last 24 months: Ankur Dhingra ($625,448.10), Mahkam Zanganeh ($16,895,280.15), Manmeet Singh Soni ($4,999,999.20), and Robert W Duggan ($395,314,374.00).

Insiders have purchased a total of 395,791,575 SMMT shares in the last 24 months for a total of $417,835,101.45 bought.

Summit Therapeutics Key Executives

  • Mr. Robert W. DugganMr. Robert W. Duggan (Age 80)
    Co-CEO & Executive Chairman
  • Dr. Mahkam Zanganeh D.D.S. (Age 54)
    M.B.A., Co-CEO, President & Director
    Compensation: $657.81k
  • Mr. Manmeet Singh Soni (Age 46)
    COO, CFO & Director
    Compensation: $591.5k
  • Prof. Dame Kay Davies DBE (Age 73)
    FRS CBE, Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor
  • Mr. Bhaskar Anand (Age 46)
    Chief Accounting Officer & Head of Finance
  • Ms. Abby Guzman Murphy
    Head of Human Resources
  • Ms. Divya Chari (Age 56)
    Head of Global Clinical Operations
  • Mr. Dave Gancarz
    Chief Business & Strategy Officer
  • Dr. Betty Y. Chang Ph.D.
    Head of Research, Oncology & Inflammation
  • Dr. Fong Clow
    Chief Biometrics Officer


This page (NASDAQ:SMMT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners